Dongsung Erdosetine Capsule (Erdosetine)

Adult dose

Adults: 300 mg of erdosteine per dose, administered orally 2～3 times daily. When administered for acute respiratory disease, do not administer continuously for more than 10 days.

This medication should not be used in certain patients. First, those allergic to this drug or its components should avoid taking it. Patients with liver cirrhosis or certain enzyme deficiencies should also not take this medication. Individuals with peptic ulcers should refrain from using this drug. Those with severely impaired kidney function and critically decreased liver function should not take this medication. Additionally, this medication contains lactose, so individuals with lactose intolerance or related genetic disorders should avoid it. This medication should be used with caution in patients with slightly impaired liver function. In such cases, the dosage should not exceed 300 mg per day. Diabetic patients or those on a low-calorie diet should be particularly careful when using this medication in syrup form. Furthermore, patients allergic to the dye Yellow No. 5 in this medication should exercise caution. Overdosing on this medication may lead to symptoms such as sweating, dizziness, and facial flushing. Neurological and respiratory side effects such as headaches, cold symptoms, and difficulty breathing have been reported. Digestive issues may manifest as taste disturbance, nausea, vomiting, diarrhea, abdominal pain, and heartburn. Skin reactions may include hives, erythema, and eczema. Various side effects such as fatigue, dyspepsia, rash, and itching were reported in post-marketing surveys in Korea, but a direct association with this medication is not confirmed. Caution should also be exercised when taking this medication with expectorants, as this may complicate the expulsion of phlegm from the bronchial passage, increasing the risk of bronchial infections. Pregnant or breastfeeding women are advised not to take this medication. While animal studies did not reveal particular problems with fetal or postpartum development, safety in humans has not been established. This medication should be kept out of reach of children. Additionally, transferring it to another container may lead to accidents or a decrease in the drug's quality, so it is recommended to maintain its original packaging.

• sweating
• dizziness
• flushing
• headache
• cold
• shortness of breath
• taste disturbance
• nausea
• vomiting
• diarrhea

Drug interactions

This medication may interact with cough medicines, so it is advisable to consult a doctor or pharmacist.

This medication should be stored in a sealed container to protect it from air and moisture. It should be kept away from extreme temperatures and stored at a normal room temperature between 1 and 30 degrees Celsius.

Appearance

A hard capsule containing white powder, with a green upper part and a yellow-orange lower part.

Package unit

30 capsules/bottle, 300 capsules/bottle